1-6 of 6
J. Gregory Cairncross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

Xueqing Lun, J. Connor Wells, Natalie Grinshtein, Jennifer C. King, Xiaoguang Hao, Ngoc-Ha Dang, Xiuling Wang, Ahmed Aman, David Uehling, Alessandro Datti, Jeffrey L. Wrana, Jacob C. Easaw, Artee Luchman, Samuel Weiss, J. Gregory Cairncross, David R. Kaplan, Stephen M. Robbins, Donna L. Senger
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (15): 3860–3875.
https://doi.org/10.1158/1078-0432.CCR-15-1798
Published: 31 July 2016
View article titled, Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
Open the PDF for Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival

H. Artee Luchman, Owen D.M. Stechishin, Stephanie A. Nguyen, Xueqing Q. Lun, J. Gregory Cairncross, Samuel Weiss
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5756–5767.
https://doi.org/10.1158/1078-0432.CCR-13-3389
Published: 13 November 2014
View article titled, Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells <em>In Vitro</em> and <em>In Vivo</em> and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival
Open the PDF for Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells <em>In Vitro</em> and <em>In Vivo</em> and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival in another window
Includes: Supplementary data
Journal Articles

Novel MSH6 Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation

Stephanie A. Nguyen, Owen D.M. Stechishin, H. Artee Luchman, Xueqing Q. Lun, Donna L. Senger, Stephen M. Robbins, J. Gregory Cairncross, Samuel Weiss
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4894–4903.
https://doi.org/10.1158/1078-0432.CCR-13-1856
Published: 14 September 2014
View article titled, Novel <em>MSH6</em> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <em>MGMT</em> Promoter Methylation
Open the PDF for Novel <em>MSH6</em> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <em>MGMT</em> Promoter Methylation in another window
Includes: Supplementary data
Journal Articles

Imaging Molecular Signatures in Oligodendroglioma: Commentary on Walker et al., pages 7182-7191

J. Gregory Cairncross
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7109–7111.
https://doi.org/10.1158/1078-0432.CCR-04-2018
Published: 08 November 2004
View article titled, Imaging Molecular Signatures in Oligodendroglioma: <subtitle>Commentary on Walker et al., pages 7182-7191</subtitle>
Open the PDF for Imaging Molecular Signatures in Oligodendroglioma: <subtitle>Commentary on Walker et al., pages 7182-7191</subtitle> in another window
Journal Articles

Imaging Correlates of Molecular Signatures in Oligodendrogliomas

Joseph F. Megyesi, Edward Kachur, Donald H. Lee, Magdalena C. Zlatescu, Rebecca A. Betensky, Peter A. Forsyth, Yoshifumi Okada, Hikaru Sasaki, Masahiro Mizoguchi, David N. Louis, J. Gregory Cairncross
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4303–4306.
https://doi.org/10.1158/1078-0432.CCR-04-0209
Published: 06 July 2004
View article titled, Imaging Correlates of Molecular Signatures in Oligodendrogliomas
Open the PDF for Imaging Correlates of Molecular Signatures in Oligodendrogliomas in another window
Journal Articles

Molecular Subtypes of Anaplastic Oligodendroglioma: Implications for Patient Management at Diagnosis

Yasushi Ino, Rebecca A. Betensky, Magdalena C. Zlatescu, Hikaru Sasaki, David R. Macdonald, Anat O. Stemmer-Rachamimov, David A. Ramsay, J. Gregory Cairncross, David N. Louis
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 839–845.
Published: 01 April 2001
View article titled, Molecular Subtypes of Anaplastic Oligodendroglioma: <subtitle>Implications for Patient Management at Diagnosis</subtitle>
Open the PDF for Molecular Subtypes of Anaplastic Oligodendroglioma: <subtitle>Implications for Patient Management at Diagnosis</subtitle> in another window